280 related articles for article (PubMed ID: 23202949)
1. MicroRNAs as active players in the pathogenesis of multiple sclerosis.
Fenoglio C; Ridolfi E; Galimberti D; Scarpini E
Int J Mol Sci; 2012 Oct; 13(10):13227-39. PubMed ID: 23202949
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs and multiple sclerosis: from physiopathology toward therapy.
Zare-Shahabadi A; Renaudineau Y; Rezaei N
Expert Opin Ther Targets; 2013 Dec; 17(12):1497-507. PubMed ID: 24053428
[TBL] [Abstract][Full Text] [Related]
3. Expression, regulation and function of microRNAs in multiple sclerosis.
Ma X; Zhou J; Zhong Y; Jiang L; Mu P; Li Y; Singh N; Nagarkatti M; Nagarkatti P
Int J Med Sci; 2014; 11(8):810-8. PubMed ID: 24936144
[TBL] [Abstract][Full Text] [Related]
4. The emerging role of microRNAs in multiple sclerosis.
Junker A; Hohlfeld R; Meinl E
Nat Rev Neurol; 2011 Jan; 7(1):56-9. PubMed ID: 21151203
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs associated with the pathogenesis of multiple sclerosis.
Huang Q; Xiao B; Ma X; Qu M; Li Y; Nagarkatti P; Nagarkatti M; Zhou J
J Neuroimmunol; 2016 Jun; 295-296():148-61. PubMed ID: 27235360
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated Network of miRNAs Involved in the Pathogenesis of Multiple Sclerosis.
Dolati S; Marofi F; Babaloo Z; Aghebati-Maleki L; Roshangar L; Ahmadi M; Rikhtegar R; Yousefi M
Biomed Pharmacother; 2018 Aug; 104():280-290. PubMed ID: 29775896
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of translational regulation by microRNAs in multiple sclerosis.
Junker A
FEBS Lett; 2011 Dec; 585(23):3738-46. PubMed ID: 21453702
[TBL] [Abstract][Full Text] [Related]
8. miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing.
Guerau-de-Arellano M; Alder H; Ozer HG; Lovett-Racke A; Racke MK
J Neuroimmunol; 2012 Jul; 248(1-2):32-9. PubMed ID: 22078708
[TBL] [Abstract][Full Text] [Related]
9. miRNA contributions to pediatric-onset multiple sclerosis inferred from GWAS.
Rhead B; Shao X; Graves JS; Chitnis T; Waldman AT; Lotze T; Schreiner T; Belman A; Krupp L; Greenberg BM; Weinstock-Guttman B; Aaen G; Tillema JM; Rodriguez M; Hart J; Caillier S; Ness J; Harris Y; Rubin J; Candee MS; Gorman M; Benson L; Mar S; Kahn I; Rose J; Casper TC; Quach H; Quach D; Schaefer C; Waubant E; Barcellos LF;
Ann Clin Transl Neurol; 2019 Jun; 6(6):1053-1061. PubMed ID: 31211169
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA in multiple sclerosis.
Gao Y; Han D; Feng J
Clin Chim Acta; 2021 May; 516():92-99. PubMed ID: 33545109
[TBL] [Abstract][Full Text] [Related]
11. Small non-coding RNAs as important players, biomarkers and therapeutic targets in multiple sclerosis: A comprehensive overview.
Piket E; Zheleznyakova GY; Kular L; Jagodic M
J Autoimmun; 2019 Jul; 101():17-25. PubMed ID: 31014917
[TBL] [Abstract][Full Text] [Related]
12. Assessment of expression profile of microRNAs in multiple sclerosis patients treated with fingolimod.
Mazdeh M; Kordestani H; Komaki A; Eftekharian MM; Arsang-Jang S; Branicki W; Taheri M; Ghafouri-Fard S
J Mol Neurosci; 2020 Aug; 70(8):1274-1281. PubMed ID: 32215780
[TBL] [Abstract][Full Text] [Related]
13. [MiRNAs: new actors in the physiopathology of multiple sclerosis].
Jagot F; Davoust N
Med Sci (Paris); 2017; 33(6-7):620-628. PubMed ID: 28990564
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNAs as biomarkers in progressive multiple sclerosis.
Vistbakka J; Elovaara I; Lehtimäki T; Hagman S
Mult Scler; 2017 Mar; 23(3):403-412. PubMed ID: 27246141
[TBL] [Abstract][Full Text] [Related]
15. Identification of the miRNA-mRNA regulatory network in multiple sclerosis.
Yang Q; Pan W; Qian L
Neurol Res; 2017 Feb; 39(2):142-151. PubMed ID: 27809691
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA patents in demyelinating diseases: a new diagnostic and therapeutic perspective.
Li JS; Yao ZX
Recent Pat DNA Gene Seq; 2012 Apr; 6(1):47-55. PubMed ID: 22239683
[TBL] [Abstract][Full Text] [Related]
17. Integration of MicroRNA databases to study MicroRNAs associated with multiple sclerosis.
Angerstein C; Hecker M; Paap BK; Koczan D; Thamilarasan M; Thiesen HJ; Zettl UK
Mol Neurobiol; 2012 Jun; 45(3):520-35. PubMed ID: 22549745
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs change the games in central nervous system pharmacology.
Marangon D; Raffaele S; Fumagalli M; Lecca D
Biochem Pharmacol; 2019 Oct; 168():162-172. PubMed ID: 31251938
[TBL] [Abstract][Full Text] [Related]
19. Circular RNAs as a novel layer of regulatory mechanism in multiple sclerosis.
Zurawska A; Mycko MP; Selmaj KW
J Neuroimmunol; 2019 Sep; 334():576971. PubMed ID: 31163273
[TBL] [Abstract][Full Text] [Related]
20. Expression of disease-related miRNAs in white-matter lesions of progressive multiple sclerosis brains.
Tripathi A; Volsko C; Datta U; Regev K; Dutta R
Ann Clin Transl Neurol; 2019 May; 6(5):854-862. PubMed ID: 31139683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
